11 Results for "

H3K27me3/me2

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "H3K27me3/me2" in MCE Product Catalog:

65
65 Publications Verification
Cat. No.: HY-15648B
CAS No.: 1373423-53-0
Purity:  99.64%
Research Areas:  

Cancer

GSK-J4 is a potent dual inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A with IC50s of 8.6 and 6.6 μM, respectively. GSK-J4 inhibits LPS-induced TNF-α production in human primary macrophages with an IC50 of 9 μM. GSK J4 is a cell permeable proagent of GSK-J1 . GSK-J4 induces endoplasmic reticulum stress-related apoptosis .
loading...
    loading...
65
65 Publications Verification
Cat. No.: HY-15648F
CAS No.: 1797983-09-5
Purity:  99.01%
Target:  

Histone Demethylase

Research Areas:  

Cancer

GSK-J4 hydrochloride is a potent dual inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A with IC50s of 8.6 and 6.6 μM, respectively. GSK-J4 hydrochloride inhibits LPS-induced TNF-α production in human primary macrophages with an IC50 of 9 μM. GSK-J4 hydrochloride is a cell permeable proagent of GSK-J1 .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-15648
CAS No.: 1373422-53-7
Purity:  99.89%
Target:  

Histone Demethylase

Research Areas:  

Cancer

GSK-J1, a chemical probe, is a potent inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A, with IC50 of 60 nM towards KDM6B.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-15648D
CAS No.: 2309668-29-7
Purity:  98.33%
Target:  

Histone Demethylase

Research Areas:  

Cancer

GSK-J1 lithium salt is a potent inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A, with IC50 of 60 nM towards KDM6B.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-15648A
CAS No.: 1394854-52-4
Purity:  99.75%
Target:  

Histone Demethylase

Research Areas:  

Cancer

GSK-J2 is an isomer of GSK-J1 that does not have any specific activity. GSK-J1 is a potent inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A.
loading...
    loading...
Cat. No.: HY-15648FR
CAS No.: 1797983-09-5
Target:  

Histone Demethylase

Research Areas:  

Cancer

GSK-J4 (hydrochloride) (Standard) is the analytical standard of GSK-J4 (hydrochloride). This product is intended for research and analytical applications. GSK-J4 hydrochloride is a potent dual inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A with IC50s of 8.6 and 6.6 μM, respectively. GSK-J4 hydrochloride inhibits LPS-induced TNF-α production in human primary macrophages with an IC50 of 9 μM. GSK-J4 hydrochloride is a cell permeable proagent of GSK-J1 .
loading...
    loading...
Cat. No.: HY-15648BR
CAS No.: 1373423-53-0
Research Areas:  

Cancer

GSK-J4 (Standard) is the analytical standard of GSK-J4. This product is intended for research and analytical applications. GSK-J4 is a potent dual inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A with IC50s of 8.6 and 6.6 μM, respectively. GSK-J4 inhibits LPS-induced TNF-α production in human primary macrophages with an IC50 of 9 μM. GSK J4 is a cell permeable proagent of GSK-J1 . GSK-J4 induces endoplasmic reticulum stress-related apoptosis .
loading...
    loading...
Cat. No.: HY-15648G
CAS No.: 1797832-71-3
Target:  

Histone Demethylase

Research Areas:  

Cancer

GSK-J1 sodium is a potent inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A, with IC50 value of 60 nM towards KDM6B .
loading...
    loading...
Cat. No.: HY-15648I
CAS No.: 2108665-15-0
Target:  

Histone Demethylase

Research Areas:  

Cancer

GSK-J2 sodium is the sodium form of GSK-J2 (HY-15648A). GSK-J2 is an isomer of GSK-J1, and does not have any specific activity. GSK-J1 (HY-15648) is a potent inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A .
loading...
    loading...
Cat. No.: HY-P2253
Target:  

Histone Demethylase

Research Areas:  

Cancer

H3K27(Me2) (15-34), a histone peptide, is a repressive chromatin mark derived from human histone. Polycomb Repressive Complex 2 (PRC2) is a multiprotein complex that catalyzes the methylation of H3K27(Me) .
loading...
    loading...
Cat. No.: HY-122595
CAS No.: 1377997-28-8
Research Areas:  

Cancer

EZH2-IN-1 (compound 3) is a selective and SAM-competitive EZH2 and EZH1 inhibitor with an IC50s of 32 nM, 197 nM and 213 nM for EZH2wt, EZH2 Y641N mutant and EZH1, respectively. EZH2-IN-1 reduces bulk H3K27me3 and H3K27me2 levels. EZH2-IN-1 has the potential for diffuse large B cell lymphoma research .
loading...
    loading...
  • 1